Test-retest Study With [18F]PI-2620 in PSP-RS and NDC
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The overall goal of this protocol is to evaluate the imaging characteristics of [18F]PI-2620
using positron emission tomography (PET) in patients with progressive supranuclear palsy,
Richardson's syndrome (PSP-RS)